Pacific Edge [NZX: PEB], the non-invasive bladder cancer test maker, will ask shareholders to approve a boost in fee pool used to pay directors at its annual meeting, and plans to to refresh its board and replace outgoing director Colin Dawson.
The Dunedin-based company will ask shareholders at its Aug. 21 meeting to raise the maximum pool of fees to non-executive directors by $26,000 to $198,000 to cover any future appointments, the company said in a statement. Dawson, who has been a director with Pacific Edge since 2002 according to his LinkedIn profile, today announced his resignation from the board, stepping down at the meeting.
Pacific Edge is refreshing its board as it chases sales growth in the US with its Cxbladder technology, which tests for bladder cancer. Bryan Williams, who was chairman of a Nasdaq listed company, was appointed as an independent director in the past 12 months, while Bruce Nogales, a US businessman, has joined its US subsidiary, Pacific Edge Diagnostics USA, board last year, it said.
"The board has identified a number of commercialisation skills and capabilites that would be of value to the company," chairman Chris Swann said. "We are in discussion with several candidates and we hope to make an announcement on appointment of new directors in the near future."Shares of Pacific Edge rose 4.4 percent to 71 cents, and have fallen 49 percent in the past year.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Xero directors Drury, Winkler and Morgan cash in on 35% share price rally
- MARKET CLOSE: NZ shares mixed; Spark, Fletcher join Asian rally, Xero drops as Drury trims stake
- Sir Ralph Norris spells out reasons for Fonterra board departure
- iPredict closing down due to money laundering risk
- Serco's prison report challenge: Hide and Davis go head-to-head
Most listened to
- “A very ballsy thing to do” – Rodney Hide and Kelvin Davis discuss Serco’s response to Correction’s Mt Eden Prison report
- “The response from shareholders has been overwhelming” — A2 Corporation chief executive Geoff Babidge
- Greg Gent says a board of 13 people is "prehistoric"
- Arvida CEO Bill McDonald on his company's half-year net profit
- Lance Wiggs on the future of food exports
- Auckland Councillor Chris Darby on the Council's alternative funding report
- Nevil Gibson discusses his latest Editor's Insight on oil prices
- Campbell Gibson, Nick Grant and Chelsea Armitage chat about the inner workings of New Zealand media
- Paul Brislen discusses the 'snake oil' sales tactics of SalesConcepts
- Fonterra chief executive Theo Spierings reveals his ambitious China plan
- UDC Finance chief executive Wayne Percival talks about the company's profit
- Hamish McNicol discusses the latest court stories